These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 25995451

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Apelin receptors: From signaling to antidiabetic strategy.
    Chaves-Almagro C, Castan-Laurell I, Dray C, Knauf C, Valet P, Masri B.
    Eur J Pharmacol; 2015 Sep 15; 763(Pt B):149-59. PubMed ID: 26007641
    [Abstract] [Full Text] [Related]

  • 44. Apelin/APJ signaling in hypoxia-related diseases.
    He L, Xu J, Chen L, Li L.
    Clin Chim Acta; 2015 Dec 07; 451(Pt B):191-8. PubMed ID: 26436483
    [Abstract] [Full Text] [Related]

  • 45. ELABELA: a hormone essential for heart development signals via the apelin receptor.
    Chng SC, Ho L, Tian J, Reversade B.
    Dev Cell; 2013 Dec 23; 27(6):672-80. PubMed ID: 24316148
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Apelin protects heart against ischemia/reperfusion injury in rat.
    Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS.
    Peptides; 2009 Jun 23; 30(6):1144-52. PubMed ID: 19463748
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide.
    Monastero R, Magro D, Venezia M, Pisano C, Balistreri CR.
    Ageing Res Rev; 2023 Nov 23; 91():102076. PubMed ID: 37776977
    [Abstract] [Full Text] [Related]

  • 54. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin.
    Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H, Nishimura O, Fujino M.
    J Biol Chem; 2000 Jul 14; 275(28):21061-7. PubMed ID: 10777510
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
    Sato T, Kuba K.
    Nihon Yakurigaku Zasshi; 2019 Jul 14; 153(4):172-178. PubMed ID: 30971657
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure.
    Sunjaya AP, Sunjaya AF, Ferdinal F.
    Glob Cardiol Sci Pract; 2019 Sep 20; 2019(2):e201915. PubMed ID: 31799290
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The Apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury.
    Fan XF, Xue F, Zhang YQ, Xing XP, Liu H, Mao SZ, Kong XX, Gao YQ, Liu SF, Gong YS.
    Chest; 2015 Apr 20; 147(4):969-978. PubMed ID: 25375801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.